These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2433545)

  • 1. Serum vitamin B12 levels in patients with primary hepatocellular carcinoma during treatment with CB3717.
    Buamah PK; James OF; Skillen AW; Harris AL
    J Surg Oncol; 1987 Feb; 34(2):100-3. PubMed ID: 2433545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. A phase II study.
    Bassendine MF; Curtin NJ; Loose H; Harris AL; James OF
    J Hepatol; 1987 Jun; 4(3):349-56. PubMed ID: 2439582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy.
    Buamah PK; Cornell C; James OF; Skillen AW; Harris AL
    Cancer Chemother Pharmacol; 1986; 17(2):182-4. PubMed ID: 2424626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma.
    Kane SP; Murray-Lyon IM; Paradinas FJ; Johnson PJ; Williams R; Orr AH; Kohn J
    Gut; 1978 Dec; 19(12):1105-9. PubMed ID: 84776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.
    Paradinas FJ; Melia WM; Wilkinson ML; Portmann B; Johnson PJ; Murray-Lyon IM; Williams R
    Br Med J (Clin Res Ed); 1982 Sep; 285(6345):840-2. PubMed ID: 6288165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717.
    Curtin NJ; Harris AL; James OF; Bassendine MF
    Br J Cancer; 1986 Mar; 53(3):361-8. PubMed ID: 3008799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pleomorphic hepatocellular carcinoma with biochemical features of fibrolamellar hepatocellular carcinoma.
    Buamah PK; McArdle P; Bennett M; James OF; Lendrum R
    J Surg Oncol; 1986 Jun; 32(2):93-5. PubMed ID: 3014229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vitamin B12 and folate levels, vitamin B12 and folic acid binding proteins in patients with primary carcinoma of the liver.
    Areekul S; Hitanant S; Panatampon P; Chantachum Y
    Southeast Asian J Trop Med Public Health; 1977 Dec; 8(4):519-24. PubMed ID: 614714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Folate and Vitamin B12 Levels in Patients with Hepatocellular Carcinoma.
    Cui LH; Quan ZY; Piao JM; Zhang TT; Jiang MH; Shin MH; Choi JS
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27376276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin B₁₂ and its binding proteins in hepatocellular carcinoma and chronic liver diseases.
    Simonsen K; Rode A; Nicoll A; Villadsen G; Espelund U; Lim L; Angus P; Arachchi N; Vilstrup H; Nexo E; Grønbæk H
    Scand J Gastroenterol; 2014 Sep; 49(9):1096-102. PubMed ID: 24958254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
    Abbasi A; Bhutto AR; Butt N; Munir SM
    J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical value of serum ferritin in hepatocellular carcinoma.
    Simonetti RG; Craxi A; Dardanonì G; Lanzarone F; Barbaria F; Cottone M; Pagliaro L
    Hepatogastroenterology; 1985 Dec; 32(6):276-8. PubMed ID: 2419233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in serum folic acid and vitamin B12 levels in liver cirrhosis and its clinical significance].
    Zhou YJ; Liang MY; Zhang XQ
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 30(10):625-7, 658. PubMed ID: 1582342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of surgical resection for hepatocellular carcinoma.
    Choi TK; Edward CS; Fan ST; Francis PT; Wong J
    Hepatogastroenterology; 1990 Apr; 37(2):172-5. PubMed ID: 1692802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ferritin in hepatocellular carcinoma. A comparison with alphafetoprotein.
    Melia WM; Bullock S; Johnson PJ; Williams R
    Cancer; 1983 Jun; 51(11):2112-5. PubMed ID: 6188526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
    Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
    N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
    Fabris C; Basso DA; Leandro G; Meggiato T; Elba S; Panozzo MP; Del Favero G; Fogar P; Di Mario F; Naccarato R
    Cancer; 1991 Oct; 68(8):1795-8. PubMed ID: 1717126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alpha-fetoprotein levels after hepatic artery ligation and postoperative chemotherapy: correlation with clinical status in patients with hepatocellular carcinoma.
    Nagasue N; Inokuchi K; Kobayashi M; Saku M
    Cancer; 1977 Aug; 40(2):615-8. PubMed ID: 70265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum alphafoetoprotein, hepatitis B virus infection and primary hepatocellular carcinoma in Nigerians.
    Ola SO; Olubuyide IO; Ayoola EA
    East Afr Med J; 1994 Dec; 71(12):782-3. PubMed ID: 7535684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.